Cardiovascular Research Advance Access first published online on July 25, 2009
This version [Corrected Proof] published online on August 12, 2009
Cardiovascular Research, doi:10.1093/cvr/cvp262
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A novel mouse model of in situ stenting


1 Department of Cardiovascular Science, School of Medicine and Biomedical Sciences, Floor L, Medical School, Beech Hill Road, Sheffield S10 2RX, UK
2 Brivant Medical Engineering, Galway, Ireland
* Corresponding author. Tel: +44 114 2713696, Fax: +44 114 2268898, Email: j.chamberlain{at}sheffield.ac.uk
Aims: Animal models of stenting are mostly limited to larger animals or involve substantial abdominal surgery in rodents. We aimed to develop a simple, direct model of murine stenting.
Methods and results: We designed a miniature, self-expanding, nitinol wire coil stent that was pre-loaded into a metal stent sheath. This was advanced into the abdominal aorta of the mouse, via femoral access, and the stent deployed. In-stent restenosis was investigated at 1, 3, 7, and 28 days post-stenting. The model was validated by investigation of neointima formation in mice deficient in signalling via the interleukin-1 receptor (IL-1R1), compared with other injury models. Ninety-two per cent of mice undergoing the procedure were successfully stented. All stented vessels were patent. Inflammatory cells were seen in the adventitia and around the stent strut up to 3 days post-stenting. At 3 days, an early neointima was present, building to a mature neointima at 28 days. In mice lacking IL-1R1, the neointima was 64% smaller than that in wild-type controls at the 28-day timepoint, in agreement with other models.
Conclusion: This is the first description of a successful model of murine in situ stenting, using a stent specifically tailored for use in small thin-walled arteries. The procedure can be undertaken by a single operator without the need for an advanced level of microsurgical skill and is reliable and reproducible. The utility of this model is demonstrated by a reduction in in-stent restenosis in IL-1R1-deficient mice.
KEYWORDS Mouse stent model
Time for primary review: 14 days
These two individuals are joint senior authors.